Kinespir Forte

Diclofenac diethylamine, the active ingredient in Kinespir Forte, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical gel for cutaneous use. It reduces inflammation and pain in musculoskeletal conditions and is applied to the skin of adults.

GNH USA supplies Kinespir Forte as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Diclofenac diethylamine is a topical NSAID used to manage pain and inflammation in musculoskeletal disorders.

- Osteoarthritis (knee): Relieves joint pain and improves mobility. - Acute muscle sprain: Decreases localized pain and swelling. - Tendinitis: Reduces tendon inflammation and discomfort. - Bursitis: Alleviates pain around inflamed bursae. - Back strain: Provides topical analgesia for soft‑tissue back pain.

Topical diclofenac may cause skin‑related reactions and, rarely, systemic adverse events.

Common Side Effects: - Burning sensation at application site - Itching or pruritus - Redness (erythema) - Dryness or peeling of skin - Localized rash - Mild contact dermatitis

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Systemic gastrointestinal ulceration or bleeding - Renal function impairment - Hepatic enzyme elevation - Blood dyscrasias (e.g., agranulocytosis)

When using Kinespir Forte, consider the following safety measures.

- Avoid application on broken or infected skin: May increase systemic absorption. - Do not cover treated area with occlusive dressings: Can enhance drug penetration. - Limit use to the recommended surface area: Excessive area may raise systemic exposure. - Use with caution in patients with renal or hepatic impairment: Monitor function. - Contraindicated in the third trimester of pregnancy: Risk to fetus. - Store at ambient temperature: Keep in original packaging, protect from moisture and direct sunlight.

Topical diclofenac can interact with systemic medications that affect bleeding, renal function, or electrolyte balance.

Major Interactions (Avoid): - Oral anticoagulants (e.g., warfarin): Increased risk of bleeding. - Other NSAIDs or aspirin: Additive gastrointestinal and renal toxicity. - Lithium therapy: Elevated lithium levels. - Methotrexate: Enhanced methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Diuretics (e.g., furosemide): Potential for reduced renal perfusion. - Corticosteroids: Higher chance of skin thinning and ulceration. - Selective serotonin reuptake inhibitors (SSRIs): May increase bleeding tendency.